CrossrefInfokarte
Healthcare Utilization and Cost in the Two Years Before Neuromodulation Implantation Among Medicaid Enrollees with Drug-Resistant Epilepsy
ClinicoEconomics and Outcomes Research · 2025-08 · Volume 17 · 571-583
DOI: 10.2147/ceor.s551202 ↗Abstract
Kein Abstract verfügbar.
EUVIMED